0
Summaries for Patients |

Does Measuring Genetic Variations at Chromosome 9p21.3 Help to Predict Cardiovascular Disease in Women? FREE

[+] Article and Author Information

The summary below is from the full report titled “Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3.” It is in the 20 January 2009 issue of Annals of Internal Medicine (volume 150, pages 65-72). The authors are N.P. Paynter, D.I. Chasman, J.E. Buring, D. Shiffman, N.R. Cook, and P.M. Ridker.


Ann Intern Med. 2009;150(2):I-36. doi:10.7326/0003-4819-150-2-200901200-00001
Text Size: A A A

What is the problem and what is known about it so far?

Cardiovascular disease (which includes heart attacks and strokes) is a major cause of death. Traditional risk factors for cardiovascular disease include age; family history; cholesterol levels; diabetes; high blood pressure; smoking; and, more recently, C-reactive protein levels. Doctors can use equations based on these traditional risk factors to estimate the chances that a patient will develop cardiovascular disease. We have learned that genetic factors are also linked to a person's risk for cardiovascular disease. One such risk factor is genotype on chromosome 9 at location 9p21.3. It is unclear how much measuring genetic factors would improve the ability to predict the risk for cardiovascular disease. Genetic factors can be more complicated and expensive to measure than the traditional risk factors listed above.

Why did the researchers do this particular study?

To find out whether measuring genotype at chromosome 9p21.3 provides useful information about a person's risk for cardiovascular disease beyond measurement of traditional, easily available risk factors.

Who was studied?

22 129 white, female health care professionals who were participating in the Women's Genome Health Study.

How was the study done?

When the women enrolled in the study, the researchers collected information about traditional risk factors (including smoking history, family history of early cardiovascular disease, diabetes, blood pressure, and levels of cholesterol and C-reactive protein) and took blood samples to test for genotype at chromosome 9p21.3. The researchers then followed the women for several years to see who developed cardiovascular disease and predicted the risk for cardiovascular disease by using traditional risk factors alone and with the genetic information.

What did the researchers find?

The addition of the genetic information did not meaningfully improve prediction based on the traditional risk factors alone.

What were the limitations of the study?

The study included only white women, so the results might not apply to men or to people of different ethnic backgrounds.

What are the implications of the study?

At least in white women, the addition of information about genotype at chromosome 9p21.3 does not improve the ability to predict whether cardiovascular disease will develop compared with using only traditional risk factors.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)